Customize Consent Preferences

We use cookies to help you navigate efficiently and perform certain functions. You will find detailed information about all cookies under each consent category below.

The cookies that are categorized as "Necessary" are stored on your browser as they are essential for enabling the basic functionalities of the site. ... 

Always Active

Necessary cookies are required to enable the basic features of this site, such as providing secure log-in or adjusting your consent preferences. These cookies do not store any personally identifiable data.

Functional cookies help perform certain functionalities like sharing the content of the website on social media platforms, collecting feedback, and other third-party features.

Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics such as the number of visitors, bounce rate, traffic source, etc.

Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.

No cookies to display.

Advertisement cookies are used to provide visitors with customized advertisements based on the pages you visited previously and to analyze the effectiveness of the ad campaigns.

No cookies to display.

News Room

Canadians living with type 1 diabetes will have improved access to the treatments and devices they need through a new national pharmacare program 

February 29, 2024 – Ottawa – Today marks a historic moment for the type 1 diabetes (T1D) community in Canada. JDRF Canada is thrilled to have been part of the Government of Canada’s announcement of a new national pharmacare program. The organization commends the federal government for ensuring the close to 300,000 Canadians living with […]

Nova Scotia announces expanded coverage for insulin pumps and advanced glucose monitoring 

February 28, 2024 – Halifax – The Government of Nova Scotia announced a historic investment to provide better access to diabetes devices such as insulin pumps and glucose monitors for Nova Scotians with diabetes. The province will be investing $5.9 million to fund sensor-based glucose monitoring supplies, and $1.3 million to expand the Nova Scotia […]

Ensuring Canadians living with diabetes have access to the treatments and devices they need in Canada’s national pharmacare program

February 27, 2024 – Canada-wide – JDRF Canada, an organization dedicated to improving the lives of the estimated 300,000 Canadians living with type 1 diabetes (T1D) through its advocacy efforts, is awaiting the imminent announcement of a new national pharmacare program that will include coverage of diabetes medications. Insulin was discovered in Canada by Banting, […]

CIHR Research Excellence, Diversity, and Independence (REDI) Early Career Transition Awards Announced

These awards support the career development of the next generation of health researchers. The REDI awards are available to post-doctoral researchers, clinicians, and research associates from specific underrepresented groups to help them launch their research faculty careers in Canada. The 2023 awards were open only to Black people and racialized women, which previous research identified […]

JDRF Canada Op-Ed in the Hill Times, February 14, 2024

OPINION:  Canada is on track to cure type 1 diabetes. With the right support, we can get there. Research innovation is becoming increasingly competitive in the post-pandemic world and Canada is at risk of losing its foothold. An estimated 300,000 Canadians (growing at a rate of 4.4% per year) live with type 1 diabetes (T1D), […]

JDRF Canada and Sanofi Canada partner to raise awareness about autoimmune type 1 diabetes and the critical role of screening in its early detection.

Toronto, Ontario, February 20, 2024 – JDRF Canada and Sanofi Canada are announcing a partnership aimed at amplifying awareness around type 1 diabetes (T1D), a chronic autoimmune condition, and the role screening could play in the early detection of this disease. Nationally, the number of individuals diagnosed with T1D is growing at an estimated 4.4% […]

Statement from JDRF calling for a Medical Corridor in the Middle East

JDRF, the leading global type 1 diabetes (T1D) research and advocacy organization, joins healthcare and humanitarian non-profits throughout the world in calling for a medical corridor to allow immediate access to lifesaving supplies and medicines, like insulin, needed by all people living with T1D in the Middle East conflict zone. At all times, including times […]

JDRF Awards $12 Million for Phase 3 Type 1 Diabetes Kidney Disease Clinical Trial, Joins The Kidney Foundation of Canada in Driving Research to Treat Kidney Disease – JDRF

JDRF, the leading global type 1 diabetes (T1D) research and advocacy organization, has awarded $12 million to researchers Dr. Alessandro Doria with Joslin Diabetes Center, Dr. Michael Mauer with the University of Minnesota Medical School, and Dr. David Cherney at the University Health Network, University of Toronto, to conduct a pivotal clinical trial that will […]

JDRF Canada is pleased to support 4 new trainees in partnership with the Canadian Islet Research and Training Network

JDRF Canada is thrilled to continue a successful partnership with the Canadian Islet Research and Training Network (CIRTN) and announce a second cohort of co-funded trainees beginning in 2024. CIRTN was established in 2020 as a world-class training and research network with joint contributions from the University of Alberta, University of British Columbia, University of […]

Donate | Donnez